NRX Pharmaceuticals reports first-half 2026 net loss narrows
NRX Pharmaceuticals reported a first-half 2026 net loss of $18.0 million, improved from $23.1 million a year earlier, and said cash rose to $26.7 million at June 30, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.